Roberto Bugarini Selected Research

Roberto Bugarini Research Topics

5	Neoplasms (Cancer) 11/2011 - 12/2009
4	Breast Neoplasms (Breast Cancer) 03/2011 - 12/2009
4	Human Influenza (Influenza) 09/2009 - 09/2003
2	HIV Infections (HIV Infection) 10/2005 - 03/2004
2	Infections 03/2004 - 10/2002
2	Disease Progression 10/2003 - 10/2002
1	Hodgkin Disease (Hodgkin's Disease) 05/2014
1	Triple Negative Breast Neoplasms 11/2011
1	Adenocarcinoma 01/2011
1	Pain (Aches) 09/2009
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2006
1	Persian Gulf Syndrome (Gulf War Syndrome) 09/2006
1	Influenza in Birds (Avian Flu) 04/2005
1	Persistent Infection 03/2004
1	Coinfection 10/2002
1	Kaposi Sarcoma (Kaposi's Sarcoma) 03/2002

4	VaccinesIBA 09/2009 - 09/2003
3	RNA (Ribonucleic Acid)IBA 11/2011 - 12/2009
3	AnthracyclinesIBA 11/2011 - 12/2009
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2011 - 12/2009
2	HIV Protease InhibitorsIBA 01/2011 - 03/2002
2	Tamoxifen FDA LinkGeneric 04/2010 - 01/2010
2	Hormones (Hormone)IBA 04/2010 - 12/2009
2	Influenza Vaccines (Influenza Vaccine)FDA Link 09/2009 - 04/2006
2	AntibodiesIBA 09/2006 - 04/2006
1	PanobinostatIBA 05/2014
1	Chemokine CCL17IBA 05/2014
1	ChemokinesIBA 05/2014
1	CytokinesIBA 05/2014
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2011
1	Estrogen ReceptorsIBA 03/2011
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2011
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2011
1	Matrix Metalloproteinases (MMPs)IBA 01/2011
1	Indinavir (Crixivan)FDA Link 01/2011
1	Saquinavir (Invirase)FDA Link 01/2011
1	Anastrozole (Arimidex)FDA LinkGeneric 04/2010
1	Fluorouracil (Carac)FDA LinkGeneric 01/2010
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2010
1	human ERBB2 proteinIBA 12/2009
1	Subunit VaccinesIBA 09/2009
1	Inactivated VaccinesIBA 04/2006
1	Mitochondrial DNA (mtDNA)IBA 10/2005
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2003
1	Human immunodeficiency virus 1 p16 proteaseIBA 03/2002

5	Highly Active Antiretroviral Therapy (HAART) 10/2006 - 09/2003
4	Drug Therapy (Chemotherapy) 11/2011 - 12/2009
2	Therapeutics 03/2004 - 10/2002
1	Adjuvant Chemotherapy 12/2009